ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
PDSB
#3621
PDS Biotechnology Corporation Common Stock
0.6
8
-1.45%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
-1.45%
月次変化
-32.00%
6か月変化
-47.29%
1年の変化
-52.45%
以前の終値
0.6
9
Open
0.6
8
Bid
Ask
Low
0.6
8
High
0.6
8
ボリューム
6
マーケット
株
ヘルスケア
PDSB
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
37.41 M
45.4 M
45.71 M
46.63 M
48.98 M
—
Valuation ratios
Enterprise value
93.1 M
32.3 M
14.39 M
30.12 M
23.27 M
100.08 M
Price to earnings ratio
-3.26
-1.58
-1.27
-1.45
-1.23
-5.53
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-3.75
-1.7
-1.31
-1.54
-1.31
-5.85
Price to book ratio
1.14
3.13
0.47
0.66
0.62
4.88
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.2
-0.18
-0.18
-0.23
-0.26
-0.85
Return on equity %
-0.49
-0.42
-0.38
-0.59
-0.95
-2.34
Return on invested capital %
-343.75
-228.73
-273.13
-206.74
-258.04
-966.63
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.84
2.64
2.33
2.92
2.09
9.97
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.23
0.2
0.14
0.32
0.34
1
Long term debt to total equity ratio
0.55
0.48
0.28
0.81
1.26
2.84
Per share metrics
Operating cash flow per share
-0.22
-0.23
-0.22
-0.2
-0.13
-0.77
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.35
1.14
0.99
0.69
0.56
3.39
Net current asset value per share
1.42
1.24
1.05
0.73
0.6
3.61
Tangible book value per share
0.6
0.52
0.55
0.35
0.2
1.62
Working capital per share
0.92
0.77
0.6
0.48
0.31
2.16
Book value per share
0.6
0.52
0.55
0.35
0.2
1.62
ニュース
PDS 바이오텍, 3상 시험 변경… 신속 승인 경로 추가
PDS Biotech amends Phase 3 trial to add accelerated approval path
PDS Biotech reports 9.6-month progression-free survival in prostate cancer study
PDS 바이오, 암 면역치료제 PDS0101 특허 확보
PDS Biotech secures patent for cancer immunotherapy PDS0101
PDS Biotech, FDA 회의 후 주가 급등: 승인 가속화 기대
PDS Biotech stock soars after FDA meeting provides accelerated approval path
PDS 바이오텍, 3상 암 임상시험 수정안 제출
PDS Biotech submits amended protocol for phase 3 cancer trial
PDS Biotech secures new patent for cancer immunotherapy in Japan
PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why
PDS Biotech, FDA와 신속 승인 논의